Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $718,655 (100.0% shares, 0.0% debt)

Holdings (41)

APLS APELLIS PHARMACEUTICALS INC 33.2%
Value ($000) $238,527 Shares 2,618,300 Est. Cost $48.31 Unrealized +78.6%
VERONA PHARMA PLC 7.3%
Value ($000) $52,174 Shares 2,468,000 Est. Cost $17.59 Unrealized
CYMABAY THERAPEUTICS INC 7.0%
Value ($000) $50,052 Shares 4,570,918 Est. Cost $7.72 Unrealized
RCUS ARCUS BIOSCIENCES INC 5.6%
Value ($000) $39,970 Shares 1,968,000 Est. Cost $33.27 Unrealized -42.8%
ROIV ROIVANT SCIENCES LTD 5.5%
Value ($000) $39,352 Shares 3,904,000 Est. Cost $8.23 Unrealized +8.6%
MIRATI THERAPEUTICS INC 3.8%
Value ($000) $27,098 Shares 750,000 Est. Cost $52.54 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 3.6%
Value ($000) $25,783 Shares 759,898 Est. Cost $25.60 Unrealized +31.7%
VRDN VIRIDIAN THERAPEUTICS INC 3.1%
Value ($000) $21,958 Shares 923,000 Est. Cost $25.79 Unrealized -0.5%
BBIO BRIDGEBIO PHARMA INC 2.9%
Value ($000) $20,970 Shares 1,219,200 Est. Cost $30.51 Unrealized -50.7%
89BIO INC 2.8%
Value ($000) $20,216 Shares 1,066,784 Est. Cost $16.66 Unrealized
IRON DISC MEDICINE INC 2.6%
Value ($000) $18,426 Shares 415,000 Est. Cost $35.48 Unrealized 0.0%
VIR VIR BIOTECHNOLOGY INC 2.2%
Value ($000) $15,947 Shares 650,100 Est. Cost $25.11 Unrealized 0.0%
RENEO PHARMACEUTICALS INC 2.2%
Value ($000) $15,538 Shares 2,368,587 Est. Cost $6.46 Unrealized
TNDM TANDEM DIABETES CARE INC 1.6%
Value ($000) $11,655 Shares 474,929 Est. Cost $54.82 Unrealized -41.3%
AEROVATE THERAPEUTICS INC 1.5%
Value ($000) $10,662 Shares 621,712 Est. Cost $29.30 Unrealized
ITEOS THERAPEUTICS INC 1.1%
Value ($000) $7,891 Shares 596,000 Est. Cost $18.03 Unrealized
DYN DYNE THERAPEUTICS INC 1.1%
Value ($000) $7,796 Shares 692,945 Est. Cost $12.99 Unrealized -9.2%
INSM INSMED INC 1.1%
Value ($000) $7,744 Shares 367,000 Est. Cost $18.97 Unrealized 0.0%
ALPINE IMMUNE SCIENCES INC 1.1%
Value ($000) $7,710 Shares 750,000 Est. Cost $7.20 Unrealized
TVTX TRAVERE THERAPEUTICS INC 1.1%
Value ($000) $7,603 Shares 495,000 Est. Cost $21.26 Unrealized -14.4%
GERN GERON CORP 1.0%
Value ($000) $7,312 Shares 2,278,000 Est. Cost $2.84 Unrealized +0.2%
XLO XILIO THERAPEUTICS INC 0.9%
Value ($000) $6,354 Shares 2,425,000 Est. Cost $2.77 Unrealized +9.5%
ANTX AN2 THERAPEUTICS INC 0.9%
Value ($000) $6,128 Shares 720,900 Est. Cost $7.19 Unrealized 0.0%
JASPER THERAPEUTICS INC 0.9%
Value ($000) $6,121 Shares 4,468,114 Est. Cost $1.81 Unrealized
VKTX VIKING THERAPEUTICS INC 0.8%
Value ($000) $6,079 Shares 375,000 Est. Cost $4.46 Unrealized +369.3%
ANNX ANNEXON INC 0.8%
Value ($000) $5,843 Shares 1,660,000 Est. Cost $5.18 Unrealized -15.6%
GLYCOMIMETICS INC 0.7%
Value ($000) $5,220 Shares 3,000,000 Est. Cost $1.26 Unrealized
GOSS GOSSAMER BIO INC 0.7%
Value ($000) $4,750 Shares 3,958,069 Est. Cost $5.38 Unrealized -76.8%
LXRX LEXICON PHARMACEUTICALS INC 0.6%
Value ($000) $4,404 Shares 1,923,076 Est. Cost $2.65 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 0.4%
Value ($000) $3,118 Shares 75,000 Est. Cost $23.79 Unrealized
PMVP PMV PHARMACEUTICALS INC 0.4%
Value ($000) $2,942 Shares 470,000 Est. Cost $5.24 Unrealized 0.0%
CNTA CENTESSA PHARMACEUTICALS PLC 0.4%
Value ($000) $2,550 Shares 411,928 Est. Cost $3.94 Unrealized
ORIC ORIC PHARMACEUTICALS INC 0.3%
Value ($000) $2,150 Shares 277,000 Est. Cost $5.68 Unrealized 0.0%
STOK STOKE THERAPEUTICS INC 0.3%
Value ($000) $1,974 Shares 185,669 Est. Cost $27.91 Unrealized -61.9%
IVERIC BIO INC 0.3%
Value ($000) $1,967 Shares 50,000 Est. Cost Unrealized
HEPION PHARMACEUTICALS INC 0.2%
Value ($000) $1,628 Shares 155,000 Est. Cost $10.50 Unrealized
VERA VERA THERAPEUTICS INC 0.2%
Value ($000) $1,124 Shares 70,000 Est. Cost $14.69 Unrealized -38.5%
PIERIS PHARMACEUTICALS INC 0.2%
Value ($000) $1,092 Shares 6,600,000 Est. Cost $0.20 Unrealized
MAGENTA THERAPEUTICS INC 0.1%
Value ($000) $417 Shares 550,000 Est. Cost $0.76 Unrealized
INOZYME PHARMA INC 0.0%
Value ($000) $277 Shares 49,702 Est. Cost $5.57 Unrealized
GLUE MONTE ROSA THERAPEUTICS INC 0.0%
Value ($000) $136 Shares 19,900 Est. Cost $6.47 Unrealized 0.0%